Human glioblastoma cell derived transforming growth factor-β2: evidence for secretion of both high and low molecular weight biologically active forms

This publication has 20 references indexed in Scilit:

• Role for carbohydrate structures inTGF-β1 latency
  Nature, 1989
• Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide.
  Molecular and Cellular Biology, 1988
• Comparison of the biological actions of TGF beta‐1 and TGF beta‐2: Differential activity in endothelial cells
  Journal of Cellular Physiology, 1988
• Transforming growth factor-βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation
  Cellular Immunology, 1988
• Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
  The Journal of cell biology, 1988
• The glioblastoma‐derived t cell suppressor factor/ transforming growth factor‐β2 inhibits t cell growth without affecting the interaction of interleukin 2 with its receptor
  European Journal of Immunology, 1988
• Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions
  Biochemical and Biophysical Research Communications, 1985
• A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots
  Analytical Biochemistry, 1984
• Presence of immunosuppressive factors in brain-tumor cyst fluid
  Journal of Neurosurgery, 1983
• DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS
  The Journal of Experimental Medicine, 1972